Creative Planning Has $2.64 Million Holdings in Maximus, Inc. $MMS

Creative Planning boosted its position in shares of Maximus, Inc. (NYSE:MMS) by 77.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,582 shares of the health services provider’s stock after purchasing an additional 16,363 shares during the period. Creative Planning owned 0.07% of Maximus worth $2,638,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. lifted its stake in shares of Maximus by 16.3% in the 1st quarter. Envestnet Asset Management Inc. now owns 26,387 shares of the health services provider’s stock valued at $1,799,000 after purchasing an additional 3,707 shares during the last quarter. CWM LLC raised its holdings in Maximus by 18.6% during the first quarter. CWM LLC now owns 2,274 shares of the health services provider’s stock valued at $155,000 after buying an additional 357 shares in the last quarter. Victory Capital Management Inc. raised its holdings in Maximus by 7.7% during the first quarter. Victory Capital Management Inc. now owns 41,228 shares of the health services provider’s stock valued at $2,811,000 after buying an additional 2,931 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Maximus in the first quarter worth about $2,115,000. Finally, Cetera Investment Advisers boosted its stake in shares of Maximus by 5.8% during the 1st quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider’s stock worth $308,000 after acquiring an additional 247 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on MMS shares. Weiss Ratings lowered Maximus from a “buy (b-)” rating to a “hold (c+)” rating in a report on Thursday. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 27th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $90.00.

Insider Activity

In other Maximus news, insider Michelle F. Link sold 1,610 shares of the business’s stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the sale, the insider owned 13,508 shares in the company, valued at approximately $1,227,336.88. The trade was a 10.65% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.60% of the company’s stock.

Maximus Price Performance

Maximus stock opened at $87.67 on Tuesday. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $92.50. The business’s 50-day simple moving average is $85.86 and its 200 day simple moving average is $79.74. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The stock has a market cap of $4.94 billion, a price-to-earnings ratio of 16.15 and a beta of 0.57.

Maximus (NYSE:MMS) last released its earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.01). Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.34 billion. During the same period in the previous year, the company posted $1.46 EPS. The company’s quarterly revenue was up .2% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. As a group, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus’s dividend payout ratio is currently 21.58%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.